Description
Specifications
- Form: White lyophilized powder
- Standard vial size: 10mg
- Purity: ≥99% (HPLC & Mass Spec verified)
- Class: Dual GLP-1 / Glucagon receptor agonist (oxyntomodulin analog)
- Storage: Store lyophilized powder at -20°C; refrigerate at 2–8°C once reconstituted, use within 30 days
Overview
Mazdutide is a dual GLP-1/glucagon receptor agonist derived from the native gut hormone oxyntomodulin, currently under active clinical investigation for metabolic research applications, particularly in Asia-Pacific trial populations.
Mechanism & Research Findings
Mazdutide combines GLP-1 receptor-mediated satiety and insulinotropic signaling with glucagon receptor-mediated increases in energy expenditure and hepatic fatty-acid oxidation. This dual mechanism places it in the same functional research class as other oxyntomodulin-based dual agonists, and it is frequently studied comparatively against single-target GLP-1 agonists to characterize the added metabolic contribution of glucagon receptor co-activation.
Research Applications
- Dual-incretin receptor pharmacology
- Hepatic lipid metabolism and energy-expenditure research
- Comparative dual- vs. single-agonist metabolic studies
For laboratory research use only. Not for human consumption, diagnostic, or therapeutic use.


Reviews
There are no reviews yet.